Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 3Withdrawn 1Unknown 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1Breast 1

Conditions

Breast Neoplasms 3Uterine Cervical Neoplasms 1Unspecified Adult Solid Tumor, Protocol Specific 1Rectal Neoplasms 1Pancreatic Neoplasms 1Neoplasms 1Melanoma 1Genetic Diseases, Inborn 1Fatigue 1Cardiotoxicity 1Cardiomyopathies 1

Interventions

Cisplatin 44Paclitaxel 21Radiotherapy 20Brachytherapy 19Carboplatin 18Bevacizumab 7Drug Therapy 6camrelizumab 5toripalimab 4nimotuzumab 4Radiation 4Neoadjuvant Therapy 4Gemcitabine 4tislelizumab 3sintilimab 3pembrolizumab 3apatinib 3Vaccines 3TP protocol 3Surgical Procedures, Operative 3Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18 3nedaplatin 2fludarabine 2endostar protein 2anlotinib 2Topotecan 2Surveys and Questionnaires 2Sentinel Lymph Node Biopsy 2Radiotherapy, Intensity-Modulated 2Mindfulness 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Uterine Cervical Neoplasms × Restraint, Physical × Clear all
NCT00632047 2013-08-26

Early Detection of Breast Cancer and Cervical Cancer in Women in India

National Cancer Institute (NCI)

Phase 2 Unknown
151,538 enrolled
BreastGynecologic

Breast Neoplasms, Uterine Cervical Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡